ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria

Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution

(2018) Steffen Daum et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

The medicinal chemistry of ferrocene and its derivatives

(2017) Malay Patra et al.   Nature Reviews Chemistry

Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria

(2016) Sae Rin Jean et al.   ACCOUNTS OF CHEMICAL RESEARCH

Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale

(2016) Xiaoting Shu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A review of monoclonal antibody therapies in lymphoma

(2016) Esmeralda Chi-yuan Teo et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

(2016) Gianantonio Rosti et al.   Nature Reviews Clinical Oncology

Ferrocifen type anti cancer drugs

(2015) Gérard Jaouen et al.   CHEMICAL SOCIETY REVIEWS

Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents

(2015) Josephine Modica-Napolitano et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Catalytically Generated Ferrocene-Containing Guanidines as Efficient Precursors for New Redox-Active Heterometallic Platinum(II) Complexes with Anticancer Activity

(2015) Daniel Nieto et al.   ORGANOMETALLICS

A novel cyclometallated Pt(ii)–ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation

(2014) Roldán Cortés et al.   Metallomics

Detouring of cisplatin to access mitochondrial genome for overcoming resistance

(2014) S. Marrache et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent

(2013) Simon P. Wisnovsky et al.   CHEMISTRY & BIOLOGY

Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

(2013) Steven J. O'Day et al.   JOURNAL OF CLINICAL ONCOLOGY

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

(2012) A. Wiestner   BLOOD

ROS-Inducible DNA Cross-Linking Agent as a New Anticancer Prodrug Building Block

(2012) Sheng Cao et al.   CHEMISTRY-A EUROPEAN JOURNAL

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Synthesis and Selective Anticancer Activity of Organochalcogen Based Redox Catalysts

(2010) Mandy Doering et al.   JOURNAL OF MEDICINAL CHEMISTRY

Organometallic Anticancer Compounds

(2010) Gilles Gasser et al.   JOURNAL OF MEDICINAL CHEMISTRY